Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective
Su L, Wang N, Han J, Shen Y. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective. The Neuroscientist 2021, 28: 453-468. PMID: 34088252, PMCID: PMC9449437, DOI: 10.1177/10738584211021018.Peer-Reviewed Original ResearchConceptsGp1 mGluRsAttention-deficit hyperactivity disorderGroup 1 metabotropic glutamate receptorsGlutamate receptorsAutism spectrum disorderMetabotropic glutamate receptorsParkinson's diseaseAlzheimer's diseaseHyperactivity disorderIntellectual disabilityMultiple CNS disordersSpectrum disorderPsychiatric diseasesMGluRsCentral nervous systemSynaptic efficacyDisordersAutismRett syndromeDown syndromeCNS disordersHuntington's diseaseParkinsonAlzheimerSchizophrenia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply